Skip to content
healthcare.dev

BENLYSTA

NDC 49401-102, belimumab, injection, powder, lyophilized, for solution, from GlaxoSmithKline LLC.

Product NDC
49401-102
Status
Listed
Labeler
GlaxoSmithKline LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125370
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49401-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BELIMUMAB400 mg/5mL

Pharmacologic classes

B Lymphocyte Stimulator-directed Antibody Interactions [MoA]; B Lymphocyte Stimulator-specific Inhibitor [EPC]; Decreased B Lymphocyte Activation [PE]

Package NDCNDC-11Package
49401-102-01494010102011 VIAL in 1 CARTON (49401-102-01) / 5 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2fa3c528-1777-4628-8a55-a69dae2381a3
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=49401-102

Use it

Look up 49401-102 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49401-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49401-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.